Related Experiment Video
Updated: Aug 12, 2026

Enrichment of Bruch's Membrane from Human Donor Eyes
Published on: November 15, 2015
The complement system and age-related macular degeneration
1Laser and Retinal Research Unit, King's College Hospital, Denmark Hill, London, UK.
Insights
Age-related macular degeneration (AMD) is a leading cause of blindness. Research suggests the complement system, particularly Complement factor H (CFH) gene variations, contributes to AMD development, offering potential therapeutic targets.
Area of Science:
- Ophthalmology
- Immunology
- Genetics
Background:
- Age-related macular degeneration (AMD) is a primary cause of vision loss globally.
- Emerging evidence implicates the complement system in AMD pathogenesis.
- Understanding these links is crucial for developing new treatments.
Purpose of the Study:
- To review current research on the complement system's role in AMD.
- To summarize findings linking complement pathways to AMD development.
Main Methods:
- Literature review of scientific publications.
Main Results:
- The complement system comprises multiple activation pathways.
- Polymorphisms in Complement factor H (CFH) are associated with increased AMD risk.
- CFH, a regulatory protein, may be dysregulated in AMD due to genetic variations, leading to excessive complement activation.
Conclusions:
- Further investigation into the molecular mechanisms of complement-mediated AMD pathogenesis is warranted.
- Targeting the complement system holds promise for novel AMD therapies.
Purpose:
Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world. There are increasing evidences to suggest the complement system may play a significant role on the pathogenesis of AMD. In this review, we summarise the current research in this area.
Methods:
Review of literature.
Results:
The complement system is a complex system with several activation pathways. Complement factor H (CFH) polymorphisms has been associated with increase risk of AMD. CFH is an inhibitor protein; the polymorphisms might cause uncontrolled activation by initiation events.
Conclusion:
Further studies on the molecular basis of the complement-mediated pathogenesis of AMD may offer novel therapy to AMD.
Related Concept Videos
The Effect of Aging on Tissues
Photoreceptors and Visual Pathways
Complement System

